FTT.AU · Factor Therapeutics Limited

-

Please sign in to comment on FTT.AU

1 Comment

Admin

4 years, 1 month ago

Factor Therapeutics Limited is currently in a long term uptrend where the price is trading 0.0% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Factor Therapeutics Limited's total revenue rose by 119.9% to $4K since the same quarter in the previous year.

Its net income has increased by 3.3% to $-345K since the same quarter in the previous year.

Finally, its free cash flow fell by 576.7% to $-125K since the same quarter in the previous year.

Based on the above factors, Factor Therapeutics Limited gets an overall score of 4/5.

Exchange	AU
CurrencyCode	AUD
ISIN	AU0000184202
Sector	Healthcare
Industry	Biotechnology

Beta	0.42
Market Cap	521K
PE Ratio	None
Target Price	0.01
Dividend Yield	0.0%

ABOUT

Factor Therapeutics Limited

Dominion Minerals Limited, together with its subsidiary, engages in the exploration of mineral properties. It holds an option to purchase a high calcium limestone project located in Early County, south Georgia. The company was formerly known as Factor Therapeutics Limited and changed its name to Dominion Minerals Limited in September 2021. Dominion Minerals Limited was incorporated in 2002 and is based in Brisbane, Australia.

FTT.AU · Factor Therapeutics Limited

-

Factor Therapeutics Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Factor Therapeutics Limited using a moving average strategy